Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. 2002

Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.

OBJECTIVE Micrometastases are often found in regional lymph nodes of colorectal cancer (CRC). The aim of this study is to examine the extent and distribution of such lymph nodes. METHODS We immunohistochemically assessed localization and frequency of micrometastases in 878 lymph nodes from 98 patients with CRC. The anatomical position of lymph nodes was defined as level 1 to level 3 according to distance from the main tumor. RESULTS The frequency of micrometastasis increased through observation of the 4-microm-thick lymph node sections, from one to two to five slices. With five slices, micrometastasis was frequently and extensively present in 49.1, 35.7, and 53.3% patients of histologically node-negative patients, node-positive patients at level 1, and node-positive patients at level 2, respectively. We then assessed the value of the presence of micrometastasis in node-negative patients with regard to prognosis, but no significant impact was obtained. To examine the reproducibility of the results obtained with immunohistochemistry, serial sectioning (four consecutive slices at seven different levels) of lymph nodes was additionally performed in lymph nodes initially diagnosed as micrometastasis positive. Immunohistochemical detection revealed that the sectioning level highly affected the results. CONCLUSIONS Our results indicated frequent presence of micrometastasis in lymph nodes of CRC and that micrometastasis in node-negative CRC patients did not help in predicting the outcome, in part because of the limited reproducibility with immunohistochemistry.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008867 Microtomy The technique of using a microtome to cut thin or ultrathin sections of tissues embedded in a supporting substance. The microtome is an instrument that hold a steel, glass or diamond knife in clamps at an angle to the blocks of prepared tissues, which it cuts in sections of equal thickness. Thin Sectioning,Ultramicrotomy,Sectioning, Thin,Sectionings, Thin,Thin Sectionings
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses

Related Publications

Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
October 1999, Zhonghua er bi yan hou ke za zhi,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
September 1989, Der Pathologe,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
January 2003, Medicina,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
November 1997, Urology,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
January 2013, Nihon Geka Gakkai zasshi,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
January 1989, Gynakologische Rundschau,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
August 1996, The European journal of surgery = Acta chirurgica,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
December 1989, Tumori,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
February 2003, Scandinavian journal of gastroenterology,
Shingo Noura, and Hirofumi Yamamoto, and Yasuhiro Miyake, and Byung no Kim, and Osamu Takayama, and Iwao Seshimo, and Masakazu Ikenaga, and Masataka Ikeda, and Mitsugu Sekimoto, and Nariaki Matsuura, and Morito Monden
November 2003, Nihon Geka Gakkai zasshi,
Copied contents to your clipboard!